Craig Kessler, MD, MACP Lombardi Comprehensive Cancer Center Georgetown University Medical Center, Washington DC Follow-on Biologics: Effects on Thrombosis? Recently, United States Representative Henry Waxman (D-CA) introduced the “Promoting Innovation and Access to Life-Saving Medicine Act” (HR 1427). The same bill has been introduced in the United States Senate by Senator Charles Schumer (D-NY), and a competing bill, the “Pathways for Biosimilars Act” (HR 5629), has been introduced in the House by Representative Anna Eshoo (D-CA). Click here for full text of the Policy Statement in HTML; PDF dowloads are available at www.natfonline.org NATF’S Official Position on Follow-on Biologics Call to Action on Patient Safety
Home
> Thrombosis > The North American Thrombosis Foum: Call to Action for the Protection of Patient Safety
Mar
09